Crossmark

CRISPR gene-editing therapies for hypertrophic cardiomyopathy

Crossref DOI link: https://doi.org/10.1038/s41591-022-02184-5

Published Online: 2023-02-16

Published Print: 2023-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Strong, Alanna https://orcid.org/0000-0001-9261-244X
License Information

Text and Data Mining valid from 2023-02-01

Version of Record valid from 2023-02-01
More Information

Article History

First Online: 16 February 2023

Competing interests

: The author declares no competing interests.